Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging

被引:23
|
作者
Duarte, Delfim [1 ,2 ,3 ,4 ]
Amarteifio, Saoirse [5 ]
Ang, Heather [1 ]
Kong, Isabella Y. [6 ,7 ]
Ruivo, Nicola [1 ]
Pruessner, Gunnar [5 ]
Hawkins, Edwin D. [1 ,6 ,7 ]
Lo Celso, Cristina [1 ,8 ]
机构
[1] Imperial Coll London, Dept Life Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England
[2] Univ Porto, i3S, P-4200135 Porto, Portugal
[3] Univ Porto, Fac Med, Dept Biomed, P-4200319 Porto, Portugal
[4] Portuguese Inst Oncol IPO Porto, Dept Oncohematol, P-4200072 Porto, Portugal
[5] Imperial Coll London, Dept Math, Huxley Bldg, London SW7 2AZ, England
[6] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia
[7] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia
[8] Francis Crick Inst, London WC2A 3LY, England
来源
IMMUNOLOGY AND CELL BIOLOGY | 2019年 / 97卷 / 02期
基金
欧洲研究理事会; 英国生物技术与生命科学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Acute myeloid leukemia cells; chemokines; intravital imaging; lymphoblastic leukemia; PLUS G-CSF; CXCR4; CHEMOTHERAPY; CHEMOSENSITIZATION; MOBILIZATION; INHIBITION; PROGENITOR;
D O I
10.1111/imcb.12216
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The majority of acute myeloid leukemia (AML) patients have a poor response to conventional chemotherapy. The survival of chemoresistant cells is thought to depend on leukemia-bone marrow (BM) microenvironment interactions, which are not well understood. The CXCL12/CXCR4 axis has been proposed to support AML growth but was not studied at the single AML cell level. We recently showed that T-cell acute lymphoblastic leukemia (T-ALL) cells are highly motile in the BM; however, the characteristics of AML cell migration within the BM remain undefined. Here, we characterize the in vivo migratory behavior of AML cells and their response to chemotherapy and CXCR4 antagonism, using high-resolution 2-photon and confocal intravital microscopy of mouse calvarium BM and the well-established MLL-AF9-driven AML mouse model. We used the Notch1-driven T-ALL model as a benchmark comparison and AMD3100 for CXCR4 antagonism experiments. We show that AML cells are migratory, and in contrast with T-ALL, chemoresistant AML cells become less motile. Moreover, and in contrast with T-ALL, the in vivo exploratory behavior of expanding and chemoresistant AML cells is unaffected by AMD3100. These results expand our understanding of AML cells-BM microenvironment interactions, highlighting unique traits of leukemia of different lineages.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 50 条
  • [1] Molecular Characteristics of Leukemia Propagating Cells in Acute Myeloid Leukemia
    Buske, C.
    ANNALS OF HEMATOLOGY, 2013, 92 : S37 - S38
  • [2] Ex-Vivo Maintenance of Primary Acute Myeloid Leukemia Cells
    Wen, Kwun Wah
    Liu, Xiao-Lei
    Dos Santos, Cedric
    Huang, Jian
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Klein, Peter
    MODERN PATHOLOGY, 2015, 28 : 386A - 386A
  • [3] Ex-Vivo Maintenance of Primary Acute Myeloid Leukemia Cells
    Wen, Kwun Wah
    Liu, Xiao-Lei
    Dos Santos, Cedric
    Huang, Jian
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Klein, Peter
    LABORATORY INVESTIGATION, 2015, 95 : 386A - 386A
  • [4] Calreticulin Promotes Immunity Against Acute Myeloid Leukemia Cells in Vivo
    Chen, Xiufen
    Fosco, Dominick
    Kline, Douglas E.
    Kline, Justin
    BLOOD, 2014, 124 (21)
  • [5] Defining Acute Myeloid Leukemia Ontogeny in Older Patients
    Melody, Megan
    Sallman, David
    AlAli, Najla
    Ramadan, Hanadi
    Zhang, Ling
    Padron, Eric
    Sweet, Kendra
    Extermann, Martine
    List, Alan
    Lancet, Jeffery
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S275 - S275
  • [6] Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia
    Lamble, Adam
    Kosaka, Yoko
    Lo, Pierrette
    Huang, Fei
    Sasser, Kate
    Tognon, Cristina E.
    Loriaux, Marc
    Tyner, Jeffrey W.
    Druker, Brian J.
    Lind, Evan F.
    BLOOD, 2015, 126 (23)
  • [7] DEFINING THE IMMUNE MICROENVIRONMENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Lind, Evan F.
    Lamble, Adam
    Kosaka, Yoko
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [8] Defining Acute Myeloid Leukemia Ontogeny in Older Patients
    Melody, Megan
    Sallman, David A.
    Al Ali, Najla
    Ramadan, Hanadi
    Zhang, Ling
    Padron, Eric
    Sweet, Kendra
    Extermann, Martine
    List, Alan F.
    Lancet, Jeffrey E.
    Komrokji, Rami S.
    BLOOD, 2017, 130
  • [9] Defining Acute Myeloid Leukemia Ontogeny in Older Patients
    Melody, Megan
    Kuykendall, Andrew
    Sallman, David
    Al Ali, Najla
    Zhang, Ling
    Talati, Chetasi
    Padron, Eric
    Sweet, Kendra
    Extermann, Martine
    List, Alan
    Lancet, Jeffrey
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05): : 312 - 315
  • [10] Consolidation Therapy for Acute Myeloid Leukemia: Defining a Benchmark
    Luger, Selina M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (08) : 870 - +